Innolake Biopharm
PrivateLast Round
Series A
Extension
Jun 5, 2023
Total Funding Raised
$53.99M
Company Overview
Innolake Biopharm is a clinical-stage biotechnology company that develops therapeutic drugs for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innolake Biopharm Comparables
Compare Innolake Biopharm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediLink Therapeutics | 88% | |
| Minghui Pharmaceutical | 86% | |
| Duality Biotherapeutics Inc | 85% | |
Innolake Biopharm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 5, 2023 | ||||
| Early Funding | Apr 6, 2021 |
Innolake Biopharm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zhongbo Juli | Series A Extension |
| Hangzhou Heda Industry Fund | Series A Extension |
| Huagai Capital | Early Funding |
| CDH Investments | Early Funding |
| Zhongbo Venture Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2023
$14M round led by Zhongbo Juli and Hangzhou Heda Industry Fund.
- Apr 6, 2021
$40M raised with participation from CDH Investments and Huagai Capital.
Innolake Biopharm Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innolake Biopharm's valuation, stock price, and market status.